– USA, NY – Oramed Pharmaceuticals Inc. (Nasdaq: ORMP | TASE: ORMP) today announced the appointment of Ben Shapiro to its Board as an Independent Director, effective May 1, 2023.
“We are excited to welcome Ben onto our Board. Ben’s unique talents and qualifications are expected to bring real value to the current Oramed Board. We are delighted to begin working in earnest with him to build shareholder value,” said CEO, Nadav Kidron.
About Benjamin Shapiro
Ben Shapiro is a successful entrepreneur and business professional who co-founded The Daily Wire, a successful, industry-leading, international media outlet in June 2015. Since May 2015, he is the host of “The Ben Shapiro Show,” a popular podcast, and he is the author of numerous New York Times best-selling books.
Mr. Shapiro earned a B.A. in Political Science from UCLA in 2004, summa cum laude, and a law degree from Harvard Law School in 2007, cum laude.
Mr. Shapiro said, “I believe Oramed is in a unique position to utilize its current capital effectively in ways that will be beneficial to its shareholders, given its skilled management and cash position. I am happy to join Oramed’s Board in what I am sure will be an exciting future for Oramed and its shareholders.”
About Oramed Pharmaceuticals
Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. The Company’s novel Protein Oral Delivery technology is designed to protect drug integrity and increase absorption. Oramed has offices in the United States and Israel.
For more information: https://oramed.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.